Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Can we safely target the WNT pathway?
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI?
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Proteomic analysis of the anti-inflammatory action of minocycline.
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Pages
« first
‹ previous
…
166
167
168
169
170
171
172
173
174
…
next ›
last »